SymBiosis Capital Partners, LLC
BENTONVILLE, AR · CIK 2006045 · 13F filing filed 2026-02-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyBentonville, AR
$109.5m
reported value
11positions
100.0%in top 10
—no comparable previous quarter
Holdings, Q4 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| EVOMMUNE INC EVMN | $21.9m20.03% | First filing |
| VERASTEM INC VSTM | $15.4m14.10% | First filing |
| AMPLITECH GROUP INC AMPG | $13.2m12.09% | First filing |
| PRECIGEN INC PGEN | $12.5m11.45% | First filing |
| INVENTIVA SA IVA | $12.1m11.04% | First filing |
| NUVATION BIO INC NUVB | $11.2m10.23% | First filing |
| RANI THERAPEUTICS HLDGS INC RANI | $8.5m7.77% | First filing |
| AARDVARK THERAPEUTICS INC AARD | $6.3m5.71% | First filing |
| CLENE INC CLNN | $4.5m4.13% | First filing |
| GENERATION BIO CO COM NEW | $3.8m3.45% | First filing |
| SURROZEN INC *W EXP 08/01/203 | $3.0k0.00% | First filing |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| GENERATION BIO CO 13G · filed 2025-11-14 | 6.3% |